0001127602-24-009546.txt : 20240311
0001127602-24-009546.hdr.sgml : 20240311
20240311211409
ACCESSION NUMBER: 0001127602-24-009546
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240310
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parsey Merdad
CENTRAL INDEX KEY: 0001792150
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 24740028
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES, INC.
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GILEAD SCIENCES INC
DATE OF NAME CHANGE: 19930328
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-10
0000882095
GILEAD SCIENCES, INC.
GILD
0001792150
Parsey Merdad
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
Chief Medical Officer
0
Common Stock
2024-03-10
4
M
0
3455
A
96161
D
Common Stock
2024-03-10
4
M
0
6946
A
103107
D
Common Stock
2024-03-10
4
F
0
4803
75.12
D
98304
D
Restricted Stock Unit
2024-03-10
4
M
0
3455
D
Common Stock
3455
37520
D
Restricted Stock Unit
2024-03-10
4
M
0
6946
D
Common Stock
6946
30574
D
Non-qualified Stock Option (Right to Buy)
75.12
2024-03-10
4
A
0
89660
0
A
2034-03-10
Common Stock
89660
89660
D
Restricted Stock Unit
2024-03-10
4
A
0
17640
A
Common Stock
17640
48214
D
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
/s/ Amy Kim by Power of Attorney for Merdad Parsey
2024-03-11